Publication 2012
212.
Herget-Rosenthal S, Metzger J, Albalat A, Bitsika V, Mischak H.
Proteomic Biomarkers for the Early Detection of Acute Kidney Injury.
Renal Failure – The Facts, Editor: Polenakovic M, InTech; 2012, pp. 105–121.
211.
Koss MJ, Nguyen TNC, Pfister MS, Koch FH, Siwy J, Mullen W, Mischak H.
Proteomics in Exudative AMD
Investigative Ophthalmology & Visual Science 2012, 53(14):2927.
210.
Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, Mischak H, Jankowski J, Stevens R, Vlahou A, Kossida S, Perco P, Bahlmann FH.
Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles
PLoS One 2012, 7(12):e51334. Epub 2012 Dec 7.
209.
Zürbig P, Jahn H.
Use of proteomic methods in the analysis of human body fluids in Alzheimer research
Electrophoresis. 2012, 33(24):3617-30.
208.
Herget-Rosenthal S, Metzger J, Albalat A, Bitsika V, Mischak H.
Proteomic biomarkers for the early detection of acute kidney injury
Prilozi. 2012, 33(1):27-48.
View
Abstract Request
Reprint
207.
Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group.
Normal and pathologic concentrations of uremic toxins
J Am Soc Nephrol. 2012, 23(7):1258-70. Epub 2012 May 24.
View
Abstract Request
Reprint
206.
Frantzi M, Makridakis M, Vlahou A.
Biomarkers for bladder cancer aggressiveness
Curr Opin Urol. 2012, 22(5):390-6.
205.
Zürbig P, Jerums G, Hovind P, MacIsaac R, Mischak H, Nielsen SE, Panagiotopoulos S, Persson F, Rossing P.
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Diabetes 2012, 61(12):3304-13. Epub 2012 Aug 7.
View
Abstract Request
Reprint
204.
Molin L, Seraglia R, Lapolla A, Ragazzi E, Gonzalez J, Vlahou A, Schanstra JP, Albalat A, Dakna M, Siwy J, Jankowski J, Bitsika V, Mischak H, Zürbig P, Traldi P.
A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases
J Proteomics. 2012, 22;75(18):5888-97. Epub 2012 Jul 26.
View
Abstract Request
Reprint
203.
Mischak H
How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS
Proteomics Clin Appl. 2012, 6(9-10):437-42. Epub 2012 Sep 24.
View
Abstract Request
Reprint
202.
Weissinger EM, Hamwi I, Dobbelstein C, Schleuning M, Metzger J, Hambach L, Holler E, Greinix H, Borchert U, Morgan M,
Multicentre, prospective and blind validation of acute graft-versus-host-disease-specific proteomic patterns in a large patient cohort: prediction of acute GvHD grade III and IV.
Bone Marrow Transplantation 2012, 47(Suppl):S13–S14.
201.
Mischak H.
Characterization and validation of CE-MS-based urinary proteome biomarker analysis for the early detection of diabetic nephropathy.
Clinical Chemistry and Laboratory Medicine
2012, 50(9):A219.
200.
Herget-Rosenthal S, Metzger J, Albalat A, Bitsika V, Mischak H.
Proteomic Biomarkers for the Early Detection of Acute Kidney Injury
Renal Failure – The Facts
2012, Editor: Polenakovic M, pp.105–122.
199.
Kuznetsova T, Mischak H, Mullen W, Staessen JA
Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction
Eur Heart J. 2012, 33(18):2342-50. Epub 2012 Jul 11.
View
Abstract Request
Reprint
198.
Dawson J, Walters M, Delles C, Mischak H, Mullen W.
Urinary proteomics to support diagnosis of stroke
PLoS One. 2012, 7(5):e35879. Epub 2012 May 16.
View
Abstract Request
Reprint
197.
Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A.
Implementation of proteomic biomarkers: making it work
Eur J Clin Invest. 2012, 42(9):1027-1036. Epub 2012 Apr 21.
View
Abstract Request
Reprint
196.
Mullen W, Albalat A, Gonzalez J, Zerefos P, Siwy J, Franke J, Mischak H.
Performance of different separation methods interfaced in the same MS-reflection TOF detector: A comparison of performance between CE versus HPLC for biomarker analysis
Electrophoresis 2012, 33(4):567-74.
View
Abstract Request
Reprint
195.
Rouse R, Siwy J, Mullen W, Mischak H, Metzger J, Hanig J
Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat
PLoS ONE 2012, 7(4): e34606.
View
Abstract Request
Reprint
194.
von zur Muhlen C, Schiffer E, Sackmann C, Zürbig P, Neudorfer I, Zirlik A, Htun N, Iphöfer A, Jänsch L, Mischak H, Bode C, Chen YC, Peter K
Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new biomarkers in mouse and human atherosclerosis
Mol Cell Proteomics 2012, 11(7):M111.013847. Epub 2012 Feb 27.
193.
Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M, Vlahou A.
Profilin 1 is a potential biomarker for bladder cancer aggressiveness
Mol Cell Proteomics. 2012, 11(4):M111.009449. Epub 2011 Dec 8.
192.
Drube J, Schiffer E, Lau E, Petersen C, Kirschstein M, Kemper M, Lichtinghagen R, Ure B, Mischak H, Pape L, Ehrich JH
Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux
Pediatrics. 2012, 129(2):e356-63. Epub 2012 Jan 23.
View
Abstract Request
Reprint
191.
Bandin F, Siwy J, Breuil B, Mischak H, Bascands JL, Decramer S, Schanstra JP
Urinary Proteome Analysis at 5-Year Followup of Patients With Nonoperated Ureteropelvic Junction Obstruction Suggests Ongoing Kidney Remodeling
J Urol. 2012, 187(3):1006-11. Epub 2012 Jan 20.
View
Abstract Request
Reprint
190.
Schiffer E, Bick C, Grizelj B, Pietzker S, Schöfer W
Urinary proteome analysis for prostate cancer diagnosis: Cost-effective application in routine clinical practice in Germany
Int J Urol. 2012, 19(2):118-25. Epub 2011 Nov 22
View
Abstract Request
Reprint